A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

NCT ID: NCT01461980

Last Updated: 2018-12-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

2648 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-28

Study Completion Date

2014-05-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a clinical study to assess the safety, tolerance and immunogenic response to MCV4(quadrivalent meningococcal polysaccharide conjugate, meningococcal serogroups A,C,Y, and W135), Tdap (diphtheria, tetanus, and acellular pertussis), and bivalent rLP2086 vaccine. Healthy male and female subjects, between the ages of 10 to 12 years old, will be randomized into 1 of 3 groups. The subjects, investigators, site staff and sponsor will be blinded to all injections given throughout the study. An unblinded administrator will be responsible to administer the vaccinations to all subjects and will be unblinded to the subject randomization in order to determine which subjects were in randomized to group 3 so they may receive their catch-up vaccinations of MCV4 and Tdap. A final telephone contact will be conducted with all subjects 6-months post their last vaccination to obtain safety information.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccines Meningococcal Vaccines

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

vaccine rLP2086 MCV4 Tdap meningitis B N. meningitidis serogroup B adolescents observer-blind

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MCV4 + Tdap+ rLP2086

Group 1 - MCV4 + Tdap + rLP2086

Group Type ACTIVE_COMPARATOR

rLP2086 + MCV4 + Tdap

Intervention Type BIOLOGICAL

At visit 1, group 1 will receive MCV4 + Tdap vaccines concomitantly with an injection of rLP2086. At visits 3 and 5 (Months 2 and 6), group 1 will receive an injection of rLP2086.

MCV4 + Tdap + saline

Group 2, MCV4 + Tdap+ saline

Group Type ACTIVE_COMPARATOR

MCV4 + Tdap + saline

Intervention Type BIOLOGICAL

At visit 1, group 2 will receive MCV4 + Tdap vaccines concomitantly with an injection of saline. At visits 3 and 5 (months 2 and 6), this group will receive a saline injection only.

Saline + saline + rLP2086

Group 3- rLP2086 + saline

Group Type PLACEBO_COMPARATOR

rLP2086 + saline

Intervention Type BIOLOGICAL

At visit 1, group 3 will receive 2 injections of saline concomitantly with an injection of rLP2086. At visits 3 and 5 (Months 2 and 6), group 3 will receive an injection of rLP2086. Subjects randomized to this group will receive MCV4 and Tdap following their final visit blood draw (Visit 6).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rLP2086 + MCV4 + Tdap

At visit 1, group 1 will receive MCV4 + Tdap vaccines concomitantly with an injection of rLP2086. At visits 3 and 5 (Months 2 and 6), group 1 will receive an injection of rLP2086.

Intervention Type BIOLOGICAL

MCV4 + Tdap + saline

At visit 1, group 2 will receive MCV4 + Tdap vaccines concomitantly with an injection of saline. At visits 3 and 5 (months 2 and 6), this group will receive a saline injection only.

Intervention Type BIOLOGICAL

rLP2086 + saline

At visit 1, group 3 will receive 2 injections of saline concomitantly with an injection of rLP2086. At visits 3 and 5 (Months 2 and 6), group 3 will receive an injection of rLP2086. Subjects randomized to this group will receive MCV4 and Tdap following their final visit blood draw (Visit 6).

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject (and a legally authorized representative) has been informed of all pertinent aspects of the study.
* Parent /legally authorized representative and subjects who are willing and able to comply with scheduled visits, laboratory tests, and other study procedures.
* Male or female subject aged greater than or equal to 10 and \<13 years at the time of enrollment.
* Available for the entire study period and can be reached by telephone.
* Healthy subject as determined by medical history, physical examination, and judgment of the investigator.
* Has received full series (5-dose series is preferred, 4-dose catch up series is allowed) of diphtheria, tetanus and pertussis (whole cell or acellular) vaccines per country specific recommendations applicable at the time of receipt.
* Male and female subjects of childbearing potential must agree to use a highly effective method of contraception throughout the study.

Exclusion Criteria

* Previous vaccination with any meningococcal serogroup B vaccine.
* Vaccination with any diphtheria, tetanus or pertussis vaccine within 5 years of the first study vaccination.
* Previous vaccination with any MCV4 vaccine.
* A previous anaphylactic reaction to any vaccine or vaccine-related component.
* Contraindication to vaccination with MCV4 and/or Tdap vaccine.
* Subjects receiving any allergen immunotherapy with a non-licensed product or receiving allergen immunotherapy with a licensed product and are not on stable maintenance doses.
* Bleeding diathesis or condition associated with prolonged bleeding time that would contraindicate intramuscular injection.
* A known or suspected defect of the immune system that would prevent an immune response to the vaccine, such as subjects with congenital or acquired defects in B cell function, those receiving chronic systemic (oral, intravenous or intramuscular) corticosteroid therapy, or those receiving immunosuppressive therapy. Subjects with terminal complement deficiency may not be included.
* History of culture-proven disease caused by Neisseria meningitidis or Neisseria gonorrhoea.
* Significant neurological disorder or history of seizure (excluding simple febrile seizure).
* Receipt of any blood products, including immunoglobulin within 6 months before the first study vaccination.
* Current chronic use of systemic antibiotics.
* Any neuroinflammatory or autoimmune condition, including, but not limited to, transverse myelitis, uveitis, optic neuritis, and multiple sclerosis.
Minimum Eligible Age

10 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Radiant Research, Inc.

Birmingham, Alabama, United States

Site Status

Costal Clinical Research, Inc.

Daphne, Alabama, United States

Site Status

Clinical Research Advantage Inc/ East Valley Family Physicians, PLC

Chandler, Arizona, United States

Site Status

Radiant Research, Inc.

Chandler, Arizona, United States

Site Status

Clinical Research Advantage, Inc./Mesa Family Medical Center, PC

Mesa, Arizona, United States

Site Status

Clinical Research Advantage, Inc./Desert

Mesa, Arizona, United States

Site Status

Radiant Research, Inc.

Tucson, Arizona, United States

Site Status

Radiant Research, Inc.

Tucson, Arizona, United States

Site Status

The Children's Clinic of Jonesboro, PA

Jonesboro, Arkansas, United States

Site Status

Arkansas Pediatric Clinic

Little Rock, Arkansas, United States

Site Status

Kaiser Permanente Fresno

Fresno, California, United States

Site Status

Kaiser Permanente Hayward

Hayward, California, United States

Site Status

Pediatric Care Medical Group

Huntington Beach, California, United States

Site Status

Loma Linda University

Loma Linda, California, United States

Site Status

Loma Linda University Health Care Pediatric Clinic

Loma Linda, California, United States

Site Status

Loma Linda University Medical Center

Loma Linda, California, United States

Site Status

Loma Linda University Health Care - Moreno Valley Pediatrics

Moreno Valley, California, United States

Site Status

Bayview Research Group, LLC

Paramount, California, United States

Site Status

Center for Clinical Trials, LLC

Paramount, California, United States

Site Status

Kaiser Permanente Sacramento

Sacramento, California, United States

Site Status

California Research Foundation

San Diego, California, United States

Site Status

Bayview Research Group, LLC

Valley Village, California, United States

Site Status

Lynn Institute of the Rockies

Colorado Springs, Colorado, United States

Site Status

Colorado Springs Family Practice

Colorado Springs, Colorado, United States

Site Status

Radiant Research, Inc.

Denver, Colorado, United States

Site Status

Norwich Pediatric Group, P.C.

Norwich, Connecticut, United States

Site Status

University of South Florida

Tampa, Florida, United States

Site Status

Emory University School of Medicine Department of Pediatrics

Atlanta, Georgia, United States

Site Status

Emory University School of Medicine

Atlanta, Georgia, United States

Site Status

Radiant Research, Inc

Atlanta, Georgia, United States

Site Status

North Georgia Clinical Research Center dba Whites Pediatrics

Dalton, Georgia, United States

Site Status

Pediatrics and Adolescent Medicine, PA

Marietta, Georgia, United States

Site Status

Pediatrics and Adolescent Medicine

Woodstock, Georgia, United States

Site Status

Advanced Clinical Research

Meridian, Idaho, United States

Site Status

Northern Illinois Research Associates

DeKalb, Illinois, United States

Site Status

Clinical Research Advantage, Inc./ Ridge Family Practice, PC

Council Bluffs, Iowa, United States

Site Status

Heartland Research Associates, LLC

Augusta, Kansas, United States

Site Status

Heartland Research Associates, LLC

Wichita, Kansas, United States

Site Status

Via Christi Clinic, P.A.

Wichita, Kansas, United States

Site Status

Kentucky Pediatric/Adult Research

Bardstown, Kentucky, United States

Site Status

University of Louisville Pediatrics: Children and Youth Project

Louisville, Kentucky, United States

Site Status

Brownsboro Park Pediatrics

Louisville, Kentucky, United States

Site Status

Bluegrass Clinical Research, Inc.

Louisville, Kentucky, United States

Site Status

Southwestern Medical Clinic Lakeland Healthcare Affiliate

Stevensville, Michigan, United States

Site Status

Allina Health Bandana Square Clinic

Saint Paul, Minnesota, United States

Site Status

Aspen Medical Group/ Odyssey Research

Saint Paul, Minnesota, United States

Site Status

Aspen Medical Group

Saint Paul, Minnesota, United States

Site Status

The Center for Pharmaceutical Research, PC

Kansas City, Missouri, United States

Site Status

Saint Louis University

St Louis, Missouri, United States

Site Status

Mercy Health Research

St Louis, Missouri, United States

Site Status

Radiant Research, Inc.

St Louis, Missouri, United States

Site Status

Sundance Clinical Research, LLC

St Louis, Missouri, United States

Site Status

Clinical Research Advantage, Inc. / Prairie Fields Family Medicine, PC

Fremont, Nebraska, United States

Site Status

Midwest Children's Health Research Institute

Lincoln, Nebraska, United States

Site Status

Quality Clinical Research, Inc.

Omaha, Nebraska, United States

Site Status

Creighton Pediatric Infectious Diseases Creighton University Medical Center

Omaha, Nebraska, United States

Site Status

Clinical Research Center of Nevada

Henderson, Nevada, United States

Site Status

Clinical Research Center of Nevada

Las Vegas, Nevada, United States

Site Status

Child Health Care Associates

East Syracuse, New York, United States

Site Status

Duke University Medical Center - Duke Health Center

Durham, North Carolina, United States

Site Status

Durham Pediatrics

Durham, North Carolina, United States

Site Status

Duke Health Center

Durham, North Carolina, United States

Site Status

PMG Research of Raleigh, LLC -

Raleigh, North Carolina, United States

Site Status

PMG Research of Raleigh, LLC

Raleigh, North Carolina, United States

Site Status

PMG Research of Raleigh, LLC

Raleigh, North Carolina, United States

Site Status

Innovis Health

Fargo, North Dakota, United States

Site Status

Odyssey Research

Fargo, North Dakota, United States

Site Status

Radiant Research, Inc

Akron, Ohio, United States

Site Status

Cincinnati Center for Clinical Research, Satellite Site - Clinic

Cincinnati, Ohio, United States

Site Status

Cincinnati Childrens Hospital Medical Center Gamble Program for Clinical Studies

Cincinnati, Ohio, United States

Site Status

Dr. Shelly David Senders, MD Inc. dba Senders Pediatrics

Cleveland, Ohio, United States

Site Status

Senders Pediatrics

Cleveland, Ohio, United States

Site Status

Rapid Medical Research, Inc.

Cleveland, Ohio, United States

Site Status

Radiant Research

Columbus, Ohio, United States

Site Status

Ohio Pediatric Research Association

Dayton, Ohio, United States

Site Status

Ohio Pediatrics, Inc.

Dayton, Ohio, United States

Site Status

Ohio Pediatrics, Inc.

Huber Heights, Ohio, United States

Site Status

Ohio Pediatric Research

Kettering, Ohio, United States

Site Status

Christopher Brad Redden, ARNP Healthcare One Urgent Care and Family Practice

El Reno, Oklahoma, United States

Site Status

Lynn Institute of Norman (LION)

Norman, Oklahoma, United States

Site Status

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States

Site Status

Oklahoma State University - Center for Health Sciences - Pediatric Research

Tulsa, Oklahoma, United States

Site Status

Office of Richard Ohnmacht

Cranston, Rhode Island, United States

Site Status

Omega Medical Research

Warwick, Rhode Island, United States

Site Status

Radiant Research, Inc.

Anderson, South Carolina, United States

Site Status

Charleston Pediatrics

Charleston, South Carolina, United States

Site Status

PMG Research of Charleson

Mt. Pleasant, South Carolina, United States

Site Status

Internal Medicine & Pediatric Associates of Bristol, PC

Bristol, Tennessee, United States

Site Status

PMG Research of Bristol

Bristol, Tennessee, United States

Site Status

Clinical Research Associates, Inc.

Nashville, Tennessee, United States

Site Status

Tekton Research, Inc.

Austin, Texas, United States

Site Status

Radiant Research, Inc.

Dallas, Texas, United States

Site Status

Advances in Health Research, Inc

Houston, Texas, United States

Site Status

West Houston Clinical Research Service

Houston, Texas, United States

Site Status

Pediatric Healthcare of Northwest Houston

Houston, Texas, United States

Site Status

Pediatric Healthcare of Northwest Houston

Houston, Texas, United States

Site Status

Texas Center for Drug Development, Inc.

Houston, Texas, United States

Site Status

Child Care Associates

San Antonio, Texas, United States

Site Status

Clinical Trials of Texas, Inc.

San Antonio, Texas, United States

Site Status

Radiant Research, Inc.

San Antonio, Texas, United States

Site Status

First Steps Pediatrics

San Antonio, Texas, United States

Site Status

Pediatric Healthcare of Northwest Houston, PA

Tomball, Texas, United States

Site Status

Pediatric Healthcare of Northwest Houston

Tomball, Texas, United States

Site Status

Radiant Research, Inc.

Murray, Utah, United States

Site Status

J. Lewis Resarch Incorporated, Foothill Family Clinic

Salt Lake City, Utah, United States

Site Status

J. Lewis Research Inc. - Foothill Family Clinic South

Salt Lake City, Utah, United States

Site Status

Jean Brown Research

Salt Lake City, Utah, United States

Site Status

J. Lewis Research, Inc. - Jordan River Family Medicine

South Jordan, Utah, United States

Site Status

Advanced Clinical Research

West Jordan, Utah, United States

Site Status

PI-Coor Clinical Research, LLC

Burke, Virginia, United States

Site Status

Pediatric Associates of Charlottesville, PLC

Charlottesville, Virginia, United States

Site Status

Pediatric Associates of Charlottesville, PLC - West Satellite

Charlottesville, Virginia, United States

Site Status

Pediatric Associates of Charlottesville, PLC - North Satellite

Charlottesville, Virginia, United States

Site Status

The Vancouver Clinic

Vancouver, Washington, United States

Site Status

The Vancouver Clinic

Vancouver, Washington, United States

Site Status

Gundersen Clinic, LTD

La Crosse, Wisconsin, United States

Site Status

Monroe Clinic

Monroe, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Beeslaar J, Mather S, Absalon J, Eiden JJ, York LJ, Crowther G, Maansson R, Maguire JD, Peyrani P, Perez JL. Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older. Vaccine. 2022 Mar 15;40(12):1872-1878. doi: 10.1016/j.vaccine.2022.01.046. Epub 2022 Feb 11.

Reference Type DERIVED
PMID: 35164991 (View on PubMed)

Beeslaar J, Peyrani P, Absalon J, Maguire J, Eiden J, Balmer P, Maansson R, Perez JL. Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data. Infect Dis Ther. 2020 Sep;9(3):625-639. doi: 10.1007/s40121-020-00322-5. Epub 2020 Jul 17.

Reference Type DERIVED
PMID: 32681472 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6108A1-2005

Identifier Type: OTHER

Identifier Source: secondary_id

B1971015

Identifier Type: -

Identifier Source: org_study_id